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temperatures have also tended to 
delay autumn, by an average of 
about three days over the past 30 
years.
Menzel said: “Unlike some 
studies that record individual 
species, this is the first 
comprehensive examination of all 
available data at the continental 
scale, using around 550 species, 
and the timing change is very 
clear.”
Sparks said: “Not only do we 
clearly demonstrate change in the 
timing of seasons, but the change 
is much stronger in countries that 
have experienced more warming”. 
He added: “Many plant species 
grow throughout Europe, so, for 
example, a direct comparison of 
the flowering date of wild cherry 
which is two weeks earlier in the 
UK with that in Austria which is 
only three days earlier is possible 
with this huge dataset.”
But there have been some 
concerns raised about the new 
study. Meteorologist Philip Eden 
has written of his concern that 
the start point of the study was 
1971, a particularly cold spring 
across much of Europe. “It 
is worrying that there was no 
acknowledgment, in the published 
abstract at least, that the start 
of the analysis period, 1971, 
sits in the middle of a period of 
abnormally cool springs over 
western, central and northern 
Europe, including the UK, which 
lasted from the early 1950s to the 
1980s. “The spring of 1972, for 
instance, was so bad in Britain 
that many parts of the country 
failed to reach 21ºC that year until 
July 12.”
But whatever happens in terms 
of the real impact of climate 
change in temperate regions, 
events elsewhere send a worrying 
signal. Rapid declines in glaciers 
since the 1980s have been 
recorded in the Himalayas, Arctic, 
Alps, Rockies and tropics. And 
for many millions of people, these 
glacial resources provide a vital 
source of drinking water. 
First indications that more 
temperate regions of the globe, 
such as Europe, are also 
beginning to feel the effects of 
climate change must send alarm 
signals right throughout the 
temperate regions.Many Americans have an emotional 
opinion about human stem cells. 
But before you condemn those 
folks, consider this: some scientists 
seem to think that they can win 
the long- running arguments about 
stem cells by simply applying 
reason. Sorry, that’s illogical.
A case in point was published 
recently in Nature. Robert Lanza 
and colleagues at Advanced 
Cell Technology (headquartered 
conveniently in California to 
cash in on state funding for 
stem- cell research, but situated in 
Massachusetts) reported they had 
found a way to produce embryonic 
stem cells without destroying 
embryos. Sort of.
This, Lanza told the New York 
Times, would finally break the 
ethical logjam against using stem 
cells because the technology 
destroys embryos. “There is no 
rational reason left to oppose this 
research,’’ he told the Times. The 
technique piggybacks on a widely 
used practice in preimplantation 
genetic diagnostics. When an 
embryo reaches the eight-cell stage, 
one is removed for analysis. The 
other seven continue to develop 
normally with no apparent ill effects.
“The new work,” wrote the 
Washington Post, “shows that even 
a single cell plucked from an early 
human embryo can be coaxed to 
divide repeatedly in a laboratory 
dish and grow into a colony of stem 
cells, coveted for their potential to 
mend failing organs.”
The Post called it “an advance 
that could significantly reshape the 
ethical and political debates that 
have long entangled the research”. 
USA Today quoted Ronald 
Green, an ACT advisor who is also 
at Dartmouth: “It’s not often that 
technology offers a solution to an 
ethical dilemma, but this could be 
one.”
But the Gordian knot of embryo 
research is not so easily cut.
“The ethical difficulties with that 
are the eight-cell embryo could 
have become twins or triplets,” 
Mediawatch: Richard F. Harris 
reports on press reaction to 
Advanced Cell Technology’s latest 
work on human embryo cells.
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Irish Times. “Also you have no idea 
what difficulty you have made by 
taking away that one cell from the 
embryo. This is not going to sort 
out the ethical difficulties.”
And, sure enough, the White 
House had a tepid response to 
this politically charged issue. 
It produced a widely quoted 
statement that read, in part: “The 
President is hopeful that with time 
scientists can find ways of deriving 
cells like those now derived from 
human embryos but without the 
need for using embryos.”
One of the most outspoken US 
critics was Richard Doerflinger, 
at the Conference of Catholic 
Bishops. For example, he told the 
New York Times that the church 
objects to in vitro fertilization 
because, “divorcing procreation 
from the act of love made the 
embryo seem ‘more of a product 
of manufacture than a gift’”. Asked 
if he meant that the parents of a 
child conceived through in vitro 
fertilization would love it less, Mr. 
Doerflinger said he was referring 
to the clinic staff “... [who] may get 
more and more used to the idea of 
the child as manufacture”.
Critics seized on one major 
weakness in the research: though 
the scientists showed that, in 
principle, they could extract a cell 
without destroying the embryo, in 
fact that’s not what they did in this 
study. ACT started with 16 surplus 
embryos, but instead of extracting 
a single cell from each, the 
company extracted as many cells 
as they could — 91, to be exact. 
Of those, just two were cultured 
into stem-cell lines. No embryos 
survived this particular experiment. 
The Financial Times seemed to 
miss this point, noting that ACT 
had generated stem-cell lines, “by 
plucking individual cells from newly 
fertilized human embryos, which 
are not harmed in the process”.
As the Washington Post put it, 
the Nature paper, “includes a photo 
of a mature embryo, healthy and 
poised to grow into a fetus after 
having survived the removal of a 
single cell”. Doerflinger said the 
photo is deceptive because no 
embryos in the experiment were 
allowed to develop that far. He said 
that was “reminiscent of the fraud 
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Climate-induced increases in 
sea-surface temperature have 
occurred in the northeast Atlantic 
in recent years that have altered 
the distributions of many fish 
species. There are major concerns 
that the few remaining commercial 
fish species such as haddock and 
cod are now moving north into 
colder waters after their relentless 
pursuit by fishing fleets. And there 
are also worries that Britain’s 
internationally important seabird 
colonies may also be suffering 
because of shifts in key prey 
species as a result of sea surface 
temperature changes. 
So reports of more temperate 
species heading north into 
these waters is good news for 
many but well short of replacing 
the ecosystems that have long 
dominated in these waters. 
Some of the normally tropical 
and sub-tropical marlins have 
been seen in the northeast Atlantic 
recently with one caught off the 
Changes in sea-surface 
temperatures in the Atlantic are 
not only changing the distribution 
of species. Nigel Williams 
reports.
Piping hotHeadline issues: The Times in London considers the significance of new work 
 announced last month by Advanced Cell Technology, based in Massachusetts. north-east coast of England this 
summer. Unprecedented numbers 
of the spectacular and remarkable 
sunfish have also been spotted 
off the British coast, presumably 
in pursuit of jellyfish, one of the 
winners in the overfishing of 
commercial species and rising 
sea-surface temperatures.
But apart from the impact on 
species distribution, new research 
suggests that rising sea surface 
temperatures may have more 
profound effects on some fish 
species.
Increased sea temperature is 
likely to affect many other aspects 
of the biology of fishes that may 
also affect their abundance, such 
as reproduction, larval survival 
and recruitment. For example, 
within the thermal limits of a 
species, warmer temperatures 
may advance the start of the 
breeding season and, through 
the influence of temperature on 
growth rate, shorten the duration 
of the juvenile stage, which is case that brought down South 
Korean stem cell researcher Hwang 
Woo Suk early this year”.
The Los Angeles Times 
editorial page bemoaned that, 
“Science took an unnecessary 
leap forward Wednesday,” by 
attempting to find a technological 
fix to address political and religious 
objections to stem-cell research. 
“It’s an impressive advance, but 
scientists — and society — would 
be better off if they could spend 
more time searching for ways to 
cure some of humankind’s most 
debilitating diseases and less time 
trying to satisfy the demands of 
politics.”
Truth be told, the advance 
doesn’t even satisfy the demands 
of research. Scientists would really 
like to get stem cells to match the 
genetics of any given individual — 
not just a person undergoing in vitro 
fertilization. And they’d prefer a 
success rate better than 2 percent, 
which is all ACT had to offer.In a commentary for MSNBC, 
University of Pennsylvania 
ethicist Art Caplan said he was 
disappointed as he watched the 
story unfold on TV.
“The media hype machine 
was running full throttle. But, 
why? The science involved is 
not going to lead to any sort of 
ethical breakthrough,” Caplan 
wrote. Among his concerns: 
clinics will still end up producing 
embryos — many of which will 
simply be thrown away because 
some people deem it unethical to 
do anything else with them.
“Why not use the unwanted extra 
embryos rather than going through 
the rigmarole of pulling cells out of 
those that make it to the eight-cell 
stage?” Caplan asked. “What we 
have here is hype, not hope.”
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